US FDA Approves Zydus Lifesciences Blood Pressure Injection
US Food and Drug Administration (FDA) of the United States has given final approval to Zydus Lifesciences to market Norepinephrine Bitartrate Injection USP. Norepinephrine Bitartrate is indicated for restoration of blood pressure in the adult patients suffering with acute hypotensive state. The drug will be produced at the topical injectable manufacturing of the company at […]
Continue Reading